| Literature DB >> 9295332 |
J P Grenert1, W P Sullivan, P Fadden, T A Haystead, J Clark, E Mimnaugh, H Krutzsch, H J Ochel, T W Schulte, E Sausville, L M Neckers, D O Toft.
Abstract
Many functions of the chaperone, heat shock protein 90 (hsp90), are inhibited by the drug geldanamycin that specifically binds hsp90. We have studied an amino-terminal domain of hsp90 whose crystal structure has recently been solved and determined to contain a geldanamycin-binding site. We demonstrate that, in solution, drug binding is exclusive to this domain. This domain also binds ATP linked to Sepharose through the gamma-phosphate. Binding is specific for ATP and ADP and is inhibited by geldanamycin. Mutation of four glycine residues within two proposed ATP binding motifs diminishes both geldanamycin binding and the ATP-dependent conversion of hsp90 to a conformation capable of binding the co-chaperone p23. Since p23 binding requires regions outside the 1-221 domain of hsp90, these results indicate a common site for nucleotides and geldanamycin that regulates the conformation of other hsp90 domains.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9295332 DOI: 10.1074/jbc.272.38.23843
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157